Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
850 USD | +1.52% | +3.61% | +45.82% |
07/06 | Jefferies Adjusts Price Target on Eli Lilly to $957 From $925 | MT |
07/06 | US FDA Staff Flags Potential Limited Benefit of Eli Lilly's Alzheimer's Disease Drug | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+45.82% | 77TCr | |
+40.95% | 63TCr | |
-6.16% | 35TCr | |
+19.86% | 33TCr | |
+9.32% | 30TCr | |
+18.45% | 25TCr | |
+11.88% | 22TCr | |
-0.78% | 22TCr | |
+5.90% | 16TCr | |
-0.73% | 16TCr |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Transcript : Eli Lilly and Company Presents at Alzheimer?s Association International Conference 2023, Jul-17-2023 07